Genetic, developmental and personality correlates of self-mutilation in depressed patients

References

• Favazza A R. The coming of age of self-mutilation. Journal of Nervous and Mental Disease 1998; 186: 259–268
   PubMed Web of Science ®Google Scholar
• Briere J, Gil E. Self-mutilation in clinical and general population samples: prevalence, correlates, and functions. American Journal of Orthopsychiatry 1998; 68: 609–620
   PubMed Web of Science ®Google Scholar
• Ross S, Heath N. A study of the frequency of self-mutilation in a community sample of adolescents. Journal of Youth and Adolescence 2002; 31: 66–67
   Web of Science ®Google Scholar
• Zoroglu S S, Tuzun U, Sar V, et al. Suicide attempt and self-mutilation among Turkish high school students in relation with abuse, neglect and dissociation. Psychiatry and Clinical Neurosciences 2003; 57: 119–126
   PubMed Web of Science ®Google Scholar
• Robey K L, Reck J F, Giacomini K D, Barabas G, Eddey G E. Modes and patterns of self-mutilation in persons with Lesch-Nyhan disease. Developmental Medicine and Child Neurology 2003; 45: 167–171
   PubMed Web of Science ®Google Scholar
• Iglauer F, Beig C, Dimigen J, et al. Hereditary compulsive self-mutilating behaviour in laboratory rabbits. Laboratory Animals 1995; 29: 385–393
   PubMed Web of Science ®Google Scholar
• Emslie G J, Rush A J, Weinberg W A, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry 1997; 54: 1031–1037
   PubMed Web of Science ®Google Scholar
• Emslie G J, Rush A J, Weinberg W A, Kowatch R A, Carmody T, Mayes TL. Fluoxetine in child and adolescent depression: acute and maintenance treatment. Depression and Anxiety 1998; 7: 32–39
   PubMedGoogle Scholar
• Hazell P, O'Connell D, Heathcote D, Robertson J, Henry D. Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. British Medical Journal 1995; 310: 897–901
   PubMed Web of Science ®Google Scholar
• Joyce P R, Mulder R T, Luty S E, et al. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Australian and New Zealand Journal of Psychiatry 2002; 36: 384–391
   PubMed Web of Science ®Google Scholar
• Mulder R T, Watkins W G, Joyce P R, Luty S E. Age may affect response to antidepressants with serotonergic and noradrenergic actions. Journal of Affective Disorders 2003; 76: 143–149
   PubMed Web of Science ®Google Scholar
• Joyce P R, Mulder R T, Luty S E, et al. Age dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline. International Journal of Neuropsychopharmacology 2003; 6: 339–346
   PubMed Web of Science ®Google Scholar
• Joyce P R, Mulder R T, Luty S E, McKenzie J M, Sullivan P F, Cloninger C R. Borderline personality disorder in major depression: symptomatology, temperament, character, differential drug response and six month outcome. Comprehensive Psychiatry 2003; 44: 35–43
   PubMed Web of Science ®Google Scholar
• Joyce P R, Luty S E, McKenzie J M, et al. Bipolar II disorder: personality and outcome in two clinical samples. Australian and New Zealand Journal of Psychiatry 2004; 38: 433–438
   PubMed Web of Science ®Google Scholar
• Mulder R T, Joyce P R, Luty S E. The relationship of personality disorders to treatment outcome in depressed outpatients. Journal of Clinical Psychiatry 2003; 64: 259–264
   PubMed Web of Science ®Google Scholar
• Spitzer R L, Williams J B, Gibbon M, First M B. The Structured Clinical Interview for DSM-III-R (SCID): I. History, rationale, and description. Archives of General Psychiatry 1992; 49: 624–629
   PubMed Web of Science ®Google Scholar
• Montgomery S A, Asberg M A. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979; 134: 382–389
   PubMed Web of Science ®Google Scholar
• Hamilton M A. rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960; 23: 56–62
   PubMed Web of Science ®Google Scholar
• Parker G, Hadzi-Pavlovic D. Melancholia a disorder of movement and mood. Cambridge University Press, New York 1996
   Google Scholar
• Spitzer R L, Williams J B.W, Gibbon M. Structured clinical interview for dsm-iii-r personality disorders. Biometrics Research Department, New York State Psychiatric Institute, New York 1987
   Google Scholar
• Parker G, Tupling H, Brown L B. A Parental Bonding Instrument. British Journal of Medical Psychology 1979; 52: 1–10
   Web of Science ®Google Scholar
• Joyce P R, McKenzie J M, Luty S E, et al. Temperament, childhood environment and psychopathology as risk factors for avoidant and borderline personality disorders. Australian and New Zealand Journal of Psychiatry 2003; 37: 756–764
   PubMed Web of Science ®Google Scholar
• Newton C R, Graham A, Heptinstall L E, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Research 1989; 17: 2503–2516
   PubMed Web of Science ®Google Scholar
• Farfel Z, Bourne H R, Iiri T. The expanding spectrum of G protein diseases. New England Journal of Medicine 1999; 340: 1012–1020
   PubMed Web of Science ®Google Scholar
• Hamm H E. The many faces of G protein signaling. Journal of Biological Chemistry 1998; 273: 669–672
   PubMed Web of Science ®Google Scholar
• Siffert W. G protein beta3 subunit 825T allele, hypertension, obesity, and diabetic nephropathy. Nephrology, Dialysis, Transplantation 2000; 15: 1298–1306
   PubMed Web of Science ®Google Scholar
• Siffert W, Rosskopf D, Siffert G, et al. Association of a human G-protein beta3 subunit variant with hypertension. Nature Genetics 1998; 18: 45–48
   PubMed Web of Science ®Google Scholar
• Turner S T, Schwartz G L, Chapman A B, Boerwinkle E. C825T Polymorphism of the G protein beta3-subunit and antihypertensive response to a thiazide diuretic. Hypertension 2001; 37: 739–743
   PubMed Web of Science ®Google Scholar
• Bohus M, Limberger M, Ebner U, et al. Pain perception during self-reported distress and calmness in patients with borderline personality disorder and self-mutilating behavior. Psychiatry Research 2000; 95: 251–260
   PubMed Web of Science ®Google Scholar
• Kemperman I, Russ M J, Clark W C, Kakuma T, Zanine E, Harrison K. Pain assessment in self-injurious patients with borderline personality disorder using signal detection theory. Psychiatry Research 1997; 70: 175–183
   PubMed Web of Science ®Google Scholar
• Russ M J, Campbell S S, Kakuma T, Harrison K, Zanine E. EEG theta activity and pain insensitivity in self-injurious borderline patients. Psychiatry Research 1999; 89: 201–214
   PubMed Web of Science ®Google Scholar
• Herpertz S, Sass H, Favazza A. Impulsivity in self-mutilative behavior: psychometric and biological findings. Journal of Psychiatric Research 1997; 31: 451–465
   PubMed Web of Science ®Google Scholar
• Steiger H, Koerner N, Engelberg M J, Israel M, Ng Ying Kin N M, Young S N. Self-destructiveness and serotonin function in bulimia nervosa. Psychiatry Research 2001; 103: 15–26
   PubMed Web of Science ®Google Scholar
• Florkowski A, Gruszczynski W, Wawrzyniak Z. Selected biochemical parameters of blood serum in soldiers committing self-mutilation. Military Medicine 2001; 166: 375–377
   PubMed Web of Science ®Google Scholar